The release marks a significant strategic pivot for Google DeepMind and the Google AI Developers team. While the industry ...
Only three songs held the #1 spot for two weeks or less, and six held it for five weeks or more. I think there are eight good ...
ZoomInfo reports that 95% of enterprise AI projects fail to deliver ROI due to inadequate data infrastructure. Successful ...
As a tumultuous year comes to an end, the New York Times Opinion politics writer Michelle Cottle talks to the columnists ...
Week 18 in the NFL is a betting nightmare thanks to the high variance of teams resting starters for games that have no ...
In 2026, J&J expects accelerated growth in the Innovative Medicine segment to be driven by its key products as well as new ...
Jamelle Bouie, Michelle Cottle and David French convene to discuss the year that was.
For investment teams, the early gains from generative AI use have come from efficiency. But because these tools are now ...
Opinion
Zacks Investment Research on MSNOpinion

3 generic drug stocks to watch amid changing US landscape

Generic drugmakers continue to navigate a challenging U.S. market defined by persistent price erosion, intense competition and structurally thin margins. While demand for generics remains steady, ...
Every year, pop star Mariah Carey figures out a new way to reignite her signature Christmas spirit. This year, she opened her ...
AbbVie ABBV and AstraZeneca AZN are both global healthcare companies with diversified drug portfolios. Both companies have ...
The 2-bill package would tighten eligibility for Medicaid, CHIP and SNAP and institute a 'most favored nation' prescription ...